In the last trading session, 2.96 million Jaguar Health Inc (NASDAQ:JAGX) shares changed hands as the company’s beta touched 1.00. With the company’s per share price at $10.91 changed hands at $2.85 or 35.36% during last session, the market valuation stood at $7.35M. JAGX’s last price was a discount, traded about -4849.59% off its 52-week high of $540.00. The share price had its 52-week low at $4.02, which suggests the last value was 63.15% up since then. When we look at Jaguar Health Inc’s average trading volume, we note the 10-day average is 0.36 million shares, with the 3-month average coming to 38.44K.
Analysts gave the Jaguar Health Inc (JAGX) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended JAGX as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. Jaguar Health Inc’s EPS for the current quarter is expected to be -18.0.
Jaguar Health Inc (NASDAQ:JAGX) trade information
Instantly JAGX was in green as seen at the end of in last trading. With action 98.00%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -56.79%, with the 5-day performance at 98.00% in the green. However, in the 30-day time frame, Jaguar Health Inc (NASDAQ:JAGX) is 112.67% up. Looking at the short shares, we see there were 53245.0 shares sold at short interest cover period of 0.77 days.
Jaguar Health Inc (JAGX) estimates and forecasts
Year-over-year growth is forecast to reach 35.51% up from the last financial year.
Consensus estimates given by 1 financial analysts project the company’s revenue in the current quarter to hit an average of 3.29M. 1 analysts are of the opinion that Jaguar Health Inc’s revenue for the current quarter will be 3.81M. The company’s revenue for the corresponding quarters a year ago was 2.35M and 2.72M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 39.94%. The estimates for the next quarter sales put growth at 40.02%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 86.61%.
JAGX Dividends
Jaguar Health Inc is expected to release its next quarterly earnings report on 2025-Mar-30.
Jaguar Health Inc (NASDAQ:JAGX)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 14.42% of Jaguar Health Inc shares while 1.66% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 1.95%.
Among Mutual Funds, the top two as of Dec 31, 2024 were VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund . With 2.38 shares estimated at $25965.0 under it, the former controlled 0.35% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund held about 0.30% of the shares, roughly 1.99 shares worth around $21743.0.
